Sihuan Pharmaceutical Holdings Group (HK:0460) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Sihuan Pharmaceutical Holdings Group Ltd. has made a strategic move by purchasing 5 million shares for its 2022 Share Award Scheme, representing a modest 0.05% of the company’s total shares. The buy was executed at an average price of HK$0.5918 per share. The company, renowned for its medical aesthetics and biopharmaceutical endeavors, aims to solidify its position as a market leader in China.
For further insights into HK:0460 stock, check out TipRanks’ Stock Analysis page.